SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-005110
Filing Date
2015-11-16
Accepted
2015-11-16 11:09:05
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnib_10q.htm 10-Q 1092368
2 CERTIFICATION tnib_1ex311.htm EX-31.1 17061
3 CERTIFICATION tnib_1ex312.htm EX-31.2 16390
4 CERTIFICATION tnib_1ex32.htm EX-32.1 11601
  Complete submission text file 0001354488-15-005110.txt   3322728

Data Files

Seq Description Document Type Size
5 tnib-20150930.xml EX-101.INS 515221
6 tnib-20150930.xsd EX-101.SCH 37931
7 tnib-20150930_cal.xml EX-101.CAL 37857
8 tnib-20150930_def.xml EX-101.DEF 43886
9 tnib-20150930_lab.xml EX-101.LAB 227611
10 tnib-20150930_pre.xml EX-101.PRE 144736
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 151232519
SIC: 2834 Pharmaceutical Preparations